AIVITA Biomedical Appoints Paul Jenkinson and Philippe Schaison to its Board of Directors
IRVINE, Calif. – October 23, 2018 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical Attains Japanese PMDA Milestone for ROOT OF CANCER Technology
IRVINE, Calif. – October 12, 2018 – AIVITA Biomedical announced today the successful completion of the manufacturing quality consultation…
AIVITA Biomedical Announces Treatment of First Patient in Phase 2 Ovarian Cancer Trial
IRVINE, Calif. – September 20, 2018 – AIVITA Biomedical announced today that it has dosed its first of 10 patients…
AIVITA Biomedical Appoints Chief Financial Officer and Vice President of Business Development
IRVINE, Calif. – August 16, 2018 – AIVITA Biomedical, a biotech company specializing in innovative stem cell applications, announced…
AIVITA Biomedical Announces Initiation of First Clinical Site for ROOT OF CANCER Glioblastoma Trial
IRVINE, Calif. – August 14, 2018 – AIVITA Biomedical, a biotech company specializing in innovative stem cell applications, announced…
AIVITA Biomedical to Speak and Exhibit Skincare Products at August Aesthetics Conferences
IRVINE, Calif. – August 9, 2018 – AIVITA Biomedical today announced that it will be exhibiting at two upcoming aesthetics…
AIVITA Biomedical Receives $1.7 million in Funding as Part of UCI Awarded CIRM Grant to Treat Vision Loss
IRVINE, Calif. – July 17, 2018 – AIVITA Biomedical, a biotech company specializing in innovative stem cell applications, announced today…
AIVITA Biomedical Announces U.S. Food and Drug Administration Clearance of IND for Phase II Glioblastoma Multiforme Trial
IRVINE, Calif. – June 20, 2018 – AIVITA Biomedical, a biotech company specializing in innovative stem cell applications, announced today…
AIVITA Biomedical Randomizes First Patient in Phase 2 Ovarian Cancer Trial
IRVINE, Calif. – June 14, 2018 – AIVITA Biomedical announced today the randomization of its first patient in the Company’s…
AIVITA Biomedical Raises $15M USD in Series B Financing
IRVINE, Calif. – June 11, 2018 – AIVITA Biomedical, a global biotech specializing in innovative stem cell applications, announced…